Abecarnil is a Full Agonist at Some, and a Partial Agonist at Other Recombinant GABAA Receptor Subtypes
- 1 January 1993
- book chapter
- Published by Springer Nature
- Vol. 11, 50-61
- https://doi.org/10.1007/978-3-642-78451-4_5
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Molecular mechanisms of the partial allosteric modulatory effects of bretazenil at gamma-aminobutyric acid type A receptor.Proceedings of the National Academy of Sciences, 1992
- GABAA receptor subtypes immunopurified from rat brain with α subunit-specific antibodies have unique pharmacological propertiesNeuron, 1991
- Cloning, pharmacological characteristics and expression pattern of the rat GABAA receptor α4 subunitFEBS Letters, 1991
- Potency of several type I-benzodiazepine receptor ligands for inhibition of [3H]flunitrazepam binding in different rat brain tissuesEuropean Journal of Pharmacology, 1991
- Cerebellar GABAA receptor selective for a behavioural alcohol antagonistNature, 1990
- γ‐Aminobutyric AcidA Receptor α5‐Subunit Creates Novel Type II Benzodiazepine Receptor PharmacologyJournal of Neurochemistry, 1990
- Biochemical evidence for the existence of gamma-aminobutyrateA receptor iso-oligomers.Published by Elsevier ,1990
- Type I and Type II GABA A -Benzodiazepine Receptors Produced in Transfected CellsScience, 1989
- Transient Expression Shows Ligand Gating and Allosteric Potentiation of GABA A Receptor SubunitsScience, 1988
- High-efficiency transformation of mammalian cells by plasmid DNA.Molecular and Cellular Biology, 1987